Bacterial lysate add‐on therapy to reduce exacerbations in severe asthma: A double‐blind placebo‐controlled trial

BACKGROUND: Asthma exacerbations are frequently induced by respiratory tract infections (RTIs). Bacterial lysates have been described to possess immune‐modulatory effects and reduce RTIs as well as asthma symptoms in children. However, whether bacterial lysates have similar effects in adult asthma p...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boer, Geertje M., Braunstahl, Gert‐Jan, van der Ploeg, Esmee K., van Zelst, Cathelijne M., van Bruggen, Alie, Epping, Guido, van Nimwegen, Menno, Verhoeven, Gert, Birnie, Erwin, Boxma‐de Klerk, Bianca M., de Bruijn, Marjolein J. W., Stadhouders, Ralph, Hendriks, Rudi W., Tramper‐Stranders, Gerdien A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292626/
https://www.ncbi.nlm.nih.gov/pubmed/34289183
http://dx.doi.org/10.1111/cea.13990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292626/
https://www.ncbi.nlm.nih.gov/pubmed/34289183
http://dx.doi.org/10.1111/cea.13990

Ejemplares similares